| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 03/01/2006 | CN1739510A Use of sophoridine oxide in preparing anticancer medicine |
| 03/01/2006 | CN1739508A Prepn process of isocollidine for eye |
| 03/01/2006 | CN1739507A Medicine composition for treating mixed infectious disease |
| 03/01/2006 | CN1739506A Autoemulsified albendazole prepn and its prepn process |
| 03/01/2006 | CN1739505A L-ornidazole injection prepn |
| 03/01/2006 | CN1739502A Application of benzydalysine in preparing medicine for treating diabetic peripheral neuropathy |
| 03/01/2006 | CN1739501A Coated thioctic acid tablet for treating and controlling diabetic neural lesion |
| 03/01/2006 | CN1739500A (-)-epigallocatechin gallate-magnesium complex solid dispersion and its prepn and application |
| 03/01/2006 | CN1739499A (-)-epigallocatechin gallate solid dispersion and its prepn and application |
| 03/01/2006 | CN1739498A (-)-epigallocatechin gallate-calcium complex solid dispersion and its prepn and application |
| 03/01/2006 | CN1739497A Prepn process of double-layer catechin microcapsule |
| 03/01/2006 | CN1739495A Freeze dried tiopronin powder for injection and its prepn |
| 03/01/2006 | CN1739494A Orally taken self-microemulsified concentrate of all-trans vitamin A acid |
| 03/01/2006 | CN1739493A Dispersive glimepiride tablet and its prepn process |
| 03/01/2006 | CN1739492A Electrostatic self-assembly process of preparing multiple medicine controlled releasing coating in exponential increase characteristic |
| 03/01/2006 | CN1739491A Nanometer fiber slow-releasing system and its prepn process and application |
| 03/01/2006 | CN1739490A Prepn process of chewing gun with medicinal function |
| 03/01/2006 | CN1739489A Water soluble microcapsule for medicine and its production process |
| 03/01/2006 | CN1739488A High performance composite hollow konjaku capsule and its prepn process |
| 03/01/2006 | CN1739487A Medicine gel spray and its prepn |
| 03/01/2006 | CN1739486A Fat milk injection containing carbohydrate component |
| 03/01/2006 | CN1243569C Use of active P40 conjugates for nasal delivery |
| 03/01/2006 | CN1243565C Traditional Chinese medicine pain-relieving bag |
| 03/01/2006 | CN1243564C Chinese medicinal powder for treating esophagus cancer |
| 03/01/2006 | CN1243560C Medicine for treating dermatosis and its preparation method |
| 03/01/2006 | CN1243559C Herbal composition and medicament against diabetes mellitus type II manufactured thereof |
| 03/01/2006 | CN1243558C Externally applied medicine for treating bone ulcer and its preparation method |
| 03/01/2006 | CN1243557C Medicine against liver fibrillation |
| 03/01/2006 | CN1243549C Ursolic acid cyano acrylic ester nano particle freeze dried powder for ampoule agent and its preparation method |
| 03/01/2006 | CN1243548C Eye drops |
| 03/01/2006 | CN1243547C New formulation |
| 03/01/2006 | CN1243546C Microgranules insoluble in gastric fluid, method for obtaining same and pharmaceutical preparations |
| 03/01/2006 | CN1243544C Taxusol composition and its preparing process |
| 03/01/2006 | CN1243543C Bioimplant formulation |
| 03/01/2006 | CN1243539C Process for producing stable enteric sugar-coated tablet |
| 03/01/2006 | CN1243538C Ursolic acid bean phospholipid nano particle freeze drying powder for ampoule agent and its preparation method |
| 03/01/2006 | CN1243537C Use of composition containing at least one oxidative sensitive hydrophilic active ingredient through at least one maleic anhydride copolymer stabilization at cosmetic and /or skin |
| 03/01/2006 | CN1243535C Cosmetic raw material having improved properties and processes for preparing the same |
| 02/28/2006 | US7005557 Film-forming compositions for protecting skin from body fluids and articles made therefrom |
| 02/28/2006 | US7005454 Dispersion of water soluble drug in water insoluble polymer matrix |
| 02/28/2006 | US7005449 Tolterodine salts |
| 02/28/2006 | US7005448 Aminoalkyl-benzofuran-5-ol compounds for the treatment of glaucoma |
| 02/28/2006 | US7005426 Complexes enter into cells via the pathway of the folic acid receptor on the cell membranes and then kill tumor cells in vivo and suppress the growth of tumor tissues without injuring normal cells; antitumor, -carcinogenic agents |
| 02/28/2006 | US7005424 Admininstering mixtures of anticarcinogenic agents and early genes for prophylaxis of cancer, tumors or metastasis; gene expression inhibitors |
| 02/28/2006 | US7005421 Doxorubicin hydrochloride acidic solution which has not been reconstituted from lyophilizate |
| 02/28/2006 | US7005408 Anhydrous warming, non- toxic and nonirritating lubricating compositions containing polyhydric alcohols and an insulating agent. The invention also relates to methods of using such compositions for lubrication, administration of active |
| 02/28/2006 | US7005252 Serum free cultivation of primate embryonic stem cells |
| 02/28/2006 | US7005144 Antler composition and its manufacturing process |
| 02/28/2006 | US7005143 Gel materials, medical articles, and methods |
| 02/28/2006 | US7005142 pliable hydrophilic film comprising at least one binder, at least one lubricant, at least one solvent for the binder and lubricant, and an effective amount of at least one effective agent |
| 02/28/2006 | US7005141 Modified amino acids and derivatives can form non-covalent mixtures with active biological agents and in an alternate embodiment can releasably carry active agents. Modified amino acids can also form drug containing microspheres. |
| 02/28/2006 | US7005140 composition that includes a charged lipid for interaction with a charged therapeutic agent, yet which bears minimal external surface charge after formation. |
| 02/28/2006 | US7005139 Drug delivery, pharmacology and cancer chemotherapy |
| 02/28/2006 | US7005138 Intravaginal or rectal delivery of selected serotonin reuptake inhibitors (ssris); antidepressants, analgesics, treating psychological disorders, pre-menstrual dysphoric disorder and obsessive compulsive disorders |
| 02/28/2006 | US7005133 Composition and process for treating pollution |
| 02/28/2006 | US7005132 Drugs specifically bound to synthetic receptors in such a manner that active drug becomes available only in the presence of a targeted pathophysiologic receptor. |
| 02/28/2006 | US7005122 Delivery of sumatriptan, frovatriptan or naratriptan through an inhalation route |
| 02/28/2006 | US7005121 Arerosol; heating drug, vaporization, cooling |
| 02/28/2006 | US7004321 Cumulative packaging provided for the removal of filled pouches in a predetermined order |
| 02/28/2006 | US7004171 System for transvaginal drug delivery |
| 02/28/2006 | CA2170537C Enteric coated oral compositions containing bisphosphonic acid derivatives |
| 02/25/2006 | CA2479058A1 Edible films including aspartame and methods of making same |
| 02/23/2006 | WO2006020984A2 Cyclosporin formulations |
| 02/23/2006 | WO2006020980A1 Agglomeration of sterol particles having a particular size |
| 02/23/2006 | WO2006020962A2 Palatable suspending vehicle for pharmaceutical ingredients |
| 02/23/2006 | WO2006020841A2 Apparatus and method for transdermal delivery of natriuretic peptides |
| 02/23/2006 | WO2006020618A1 Compositions and methods for treating leukemia |
| 02/23/2006 | WO2006020365A2 Method for prevention or treatment of inflamatory disease |
| 02/23/2006 | WO2006020291A2 Vitamin b12 compositions |
| 02/23/2006 | WO2006020288A2 Hybrid device for cell therapies |
| 02/23/2006 | WO2006020180A2 Implantable devices and methods for delivering drugs and other substances to treat sinusitis and other disorders |
| 02/23/2006 | WO2006019659A1 Use of vitamin ds to treat kidney disease |
| 02/23/2006 | WO2006019591A1 Use of vitamin d receptor activators or vitamin d analogs to treat cardiovascular disease |
| 02/23/2006 | WO2006019524A1 Controlled ocular lens regeneration |
| 02/23/2006 | WO2006019140A1 Jelly composition |
| 02/23/2006 | WO2006018521A2 Compounds and methods for controlling alcohol intake |
| 02/23/2006 | WO2006018501A1 Galenic applications of self-emulsifying mixtures of lipidic excipients |
| 02/23/2006 | WO2006018318A1 Liquid paroxetine compositions |
| 02/23/2006 | WO2006018119A1 Novel compositions of fat-soluble substances |
| 02/23/2006 | WO2006018033A1 Formulations of bisphosphonates |
| 02/23/2006 | WO2006017994A1 An analgesic pharmaceutical composition |
| 02/23/2006 | WO2006007671A3 Therapeutically combinations |
| 02/23/2006 | WO2006002419A3 Cross-linked cellulose ii |
| 02/23/2006 | WO2005115474B1 Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
| 02/23/2006 | WO2005110082A3 Antimicrobial articles |
| 02/23/2006 | WO2005105278A8 Antisolvent emulsion solidification process |
| 02/23/2006 | WO2005105039A8 Solid pharmaceutical form comprising an ltb4 antagonist |
| 02/23/2006 | WO2005063201A3 Liposomes and liposomal compositions for vaccination and drug delivery |
| 02/23/2006 | WO2005058364A3 Preservative system |
| 02/23/2006 | WO2005048978A3 A controlled release pharmaceutical composition and a process for preparing the same |
| 02/23/2006 | WO2005048974A3 Non-tabletted, chewable, individually dosed administration forms |
| 02/23/2006 | WO2005016257A3 Process of making flowable hemostatic compositions and devices containing such compositions |
| 02/23/2006 | US20060041248 Pharmaceutical compositions delivery system and methods |
| 02/23/2006 | US20060041021 Treatment of female sexual dysfunction with vasoactive intestinal polypeptide agonists |
| 02/23/2006 | US20060041009 Pharmaceutical compound containing silymarin and carbopol, production method thereof and use of same as a regenerator of tissue and pancreatic cells with endogenous secretion damaged by diabetes mellitus |
| 02/23/2006 | US20060040969 Drug combinations comprising (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl] (3R,5S)-3,5-dihydroxyhept-6-enoic acid and an inhibitor, inducer or substrate of P450 isoenzyme 3A4 |
| 02/23/2006 | US20060040962 Pharmaceutical formulations |
| 02/23/2006 | US20060040905 Formulation of nefopam and its use in the treatment of pain |
| 02/23/2006 | US20060040891 Lipid a and other carbohydrate ligand analogs |
| 02/23/2006 | US20060040853 Methods and compositions useful for modulation of angiogenesis using protein kinase Raf and Ras |